Literature DB >> 29326079

Unlocking the full potential of open innovation in the life sciences through a classification system.

Niclas Nilsson1, Timo Minssen2.   

Abstract

A common understanding of expectations and requirements is critical for boosting research-driven business opportunities in open innovation (OI) settings. Transparent communication requires common definitions and standards for OI to align the expectations of both parties. Here, we suggest a five-level classification system for OI models, reflecting the degree of openness. The aim of this classification system is to reduce contract negotiation complexity and times between two parties looking to engage in OI. Systematizing definitions and contractual terms for OI in the life sciences helps to reduce entry barriers and boosts collaborative value generation. By providing a contractual framework with predefined rules, science will be allowed to move more freely, thus maximizing the potential of OI.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29326079     DOI: 10.1016/j.drudis.2018.01.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  4 in total

Review 1.  Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.

Authors:  Maria Angeles Martinez-Grau; Maria Alvim-Gaston
Journal:  Pharmaceut Med       Date:  2019-06

2.  Six Laws of Open Source Drug Discovery.

Authors:  Matthew H Todd
Journal:  ChemMedChem       Date:  2019-10-15       Impact factor: 3.466

3.  At the Epicenter of COVID-19-the Tragic Failure of the Global Supply Chain for Medical Supplies.

Authors:  Sonu Bhaskar; Jeremy Tan; Marcel L A M Bogers; Timo Minssen; Hishamuddin Badaruddin; Simon Israeli-Korn; Henry Chesbrough
Journal:  Front Public Health       Date:  2020-11-24

Review 4.  Crowdsourcing and open innovation in drug discovery: recent contributions and future directions.

Authors:  David C Thompson; Jörg Bentzien
Journal:  Drug Discov Today       Date:  2020-10-02       Impact factor: 7.851

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.